Genzyme Synvisc OA Therapy Boosts Margins, Holds Promise For New Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme is exploring Synvisc ankle, shoulder, hip osteoarthritis indications while ramping up its newly acquired sales force for hyaluronic acid viscosupplementation therapy.